Table 2

Changes in suboptimal clinical measures at the postintervention and 6-month post-intervention follow-up visits

Enhanced UCDECIDE Self-StudyDECIDE IndividualDECIDE Group
Postintervention6 months postinterventionPostintervention6 months postinterventionPostintervention6 months postinterventionPostintervention6 months postintervention
A1C ≥7.5%, 58 mmol/mol0.06 (0.26), P = 0.81−0.03 (0.11), P = 0.75−0.57 (0.27), P < 0.05−0.24 (0.11), P < 0.05−0.55 (0.27), P < 0.05−0.10 (0.11), P = 0.37−0.78 (0.27), P < 0.01−0.09 (0.12), P = 0.42
SBP >130 mmHg−9.43 (3.77), P < 0.05−2.48 (1.30), P = 0.06−9.69 (3.47), P < 0.01−4.04 (1.20), P = 0.001−8.25 (3.56), P < 0.05−1.59 (1.31), P = 0.23−15.13 (3.83), P < 0.001−3.59 (1.34), P < 0.01
DBP >80 mmHg−4.66 (1.95), P < 0.05−1.47 (0.67), P < 0.05−2.86 (1.82), P = 0.12−1.37 (0.62), P < 0.05−3.61 (1.94), P = 0.07−1.22 (0.68), P = 0.08−8.17 (1.98), P < 0.001−2.20 (0.67), P < 0.01
LDL >100−18.88 (7.08), P < 0.01−9.04 (2.28), P < 0.001−12.38 (7.49), P = 0.10−6.02 (2.59), P < 0.05−22.17 (7.71), P < 0.01−6.54 (2.52), P < 0.0516.91(6.87), P < 0.05−4.23 (2.19), P = 0.06
HDL <40 (men) or <50 (women)3.23 (1.94), P = 0.100.42 (0.74), P = 0.581.60 (1.81), P = 0.381.76 (0.74), P < 0.05−1.12 (2.10), P = 0.60−0.78 (0.84), P = 0.360.38 (2.48), P = 0.88−0.32 (1.20), P = 0.79
  • Results from linear mixed-effects models (baseline to postintervention and baseline to 6 months postintervention) adjusted for age, education, and PHQ-2 score. Data are presented as β coefficient (SE), P value.